DrugPatentWatch Database Preview
Drugs in Development Information for Methoxyamine
» See Plans and Pricing
What is the development status for investigational drug Methoxyamine?
Methoxyamine is an investigational drug.
There have been 6 clinical trials for Methoxyamine.
The most recent clinical trial was a Phase 1 trial, which was initiated on December 1st 2015.
The most common disease conditions in clinical trials are Lymphoma, Lung Neoplasms, and Carcinoma, Non-Small-Cell Lung. The leading clinical trial sponsors are National Cancer Institute (NCI), Case Comprehensive Cancer Center, and [disabled in preview].
There are two US patents protecting this investigational drug and twenty-nine international patents.
Summary for Methoxyamine
| US Patents | 2,453 |
| International Patents | 29,663 |
| US Patent Applications | 3,120 |
| WIPO Patent Applications | 1,880 |
| Japanese Patent Applications | 530 |
| Clinical Trial Progress | Phase 1 (2015-12-01) |
| Vendors | 29 |
Recent Clinical Trials for Methoxyamine
| Title | Sponsor | Phase |
|---|---|---|
| Methoxyamine and Temozolomide in Treating Patients With Recurrent Glioblastoma | National Cancer Institute (NCI) | Phase 2 |
| Methoxyamine, Pemetrexed Disodium, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIIA-IV Non-small Cell Lung Cancer | National Cancer Institute (NCI) | Phase 1 |
| Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Cisplatin and Pemetrexed | National Cancer Institute (NCI) | Phase 1/Phase 2 |
Clinical Trial Summary for Methoxyamine
Top disease conditions for Methoxyamine
Top clinical trial sponsors for Methoxyamine
US Patents for Methoxyamine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Methoxyamine | Start Trial | Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same | Novozymes, Inc. (Davis, CA) | Start Trial |
| Methoxyamine | Start Trial | Substituted quinoxalines as FGFR kinase inhibitors | ASTEX THERAPEUTICS LTD (Cambridge, GB) | Start Trial |
| Methoxyamine | Start Trial | Polypeptides having endoglucanase activity and polynucleotides encoding same | Novozymes Inc. (Davis, CA) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Methoxyamine
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Methoxyamine | Australia | AU2014344504 | 2033-10-30 | Start Trial |
| Methoxyamine | Brazil | BR112016008799 | 2033-10-30 | Start Trial |
| Methoxyamine | Canada | CA2927641 | 2033-10-30 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
